InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,566.46
(
1.12%
)
US TECH 100
19,292.80
(
0.00%
)
Dow Jones
40,421.36
(
0.33%
)
Brent Oil
81.69
(
0.21%
)
Bitcoin
66,493.27
(
-1.64%
)
Post# of 131
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 466
Posts 26935
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 9

Monday, 03/05/2012 8:52:04 AM

Monday, March 05, 2012 8:52:04 AM

Post# of 131
7:02AM Aegerion Pharma submits marketing applications for Lomitapide in U.S. and EU (AEGR) 17.10 : Co announced that it has submitted a New Drug Application to the FDA, and a Marketing Authorization Application to the European Medicines Agency seeking approval of Aegerion's lead investigational therapeutic, lomitapide, as an adjunct to a low fat diet and other lipid-lowering therapies to reduce cholesterol in patients with Homozygous Familial Hypercholesterolemia. Co plans to initiate a clinical study of lomitapide for the treatment of FC in 2012.


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up